Offerings
Gather-ed addresses the challenges of traditional health professional educational models through a focus on collaborative, peer-based, efficient educational process delivering formative and enjoyable learning experiences. Check out our current offerings!
Clinical updates in advancements of treatment of TNBC, HR+, HER2+, HER2-Low BC (breast cancer) ESMO Congress Updates from 2023 to 2024
This curriculum aims to evaluate the landscape of BC management, delving into the latest breakthroughs, therapies, and strategies that have transformed our approach to this complex and chronic condition. This curriculum is designed to offer you a thorough understanding of the wide range of...
Reducing the Burden of Idiopathic Hypersomnia: Diagnostic and Treatment Considerations
This online program on idiopathic hypersomnia provides healthcare professionals with an in-depth understanding of this complex sleep disorder, including its pathophysiology, diagnosis, and management strategies. Through expert-led presentations and case-based discussions, participants will gain...
Developmental and Epileptic Encephalopathies: Enhancing Patient Outcomes through Personalized Care
This curriculum is designed to empower neurologists and epileptologists with the knowledge to address the unique challenges posed by Developmental and Epileptic Encephalopathies (DEEs). Through a blend of self-study modules, live discussions, and action planning, participants will learn to...
Unleashing Innovation: The Role of Bispecific Antibodies in Managing Diffuse Large B-Cell Lymphoma
This dynamic course empowers clinicians to elevate care for DLBCL patients by connecting them with CAR-T therapy experts for real-time education and mentoring. Through interactive small-group sessions, accessible online activities, and practical tools, participants will gain the confidence and...
Beyond Numbers: Fostering Successful Primary Care Obesity Management through the Lens of Cultural Humility
Obesity is associated with significant comorbid conditions including type 2 diabetes, hypertension, cardiovascular disease, and cancer, as well as reduced quality of life and poorer mental health. While primary care providers often manage obesity-related comorbidities, obesity itself is not often...
New Frontiers with BCMA Targeting in the Treatment of Heavily Relapsed Multiple Myeloma
Multiple myeloma (MM) is a clonal plasma cell disorder arising from the bone marrow and is the second most common hematologic malignancy in the United States (US), with an incidence of approximately 35,000 new cases per year. While progression-free survival (PFS) benefit is often seen with MM...
Optimizing Clinical Advances in Mild Cognitive Impairment and Early Alzheimer’s
It is well recognized that early diagnosis and ongoing management of Alzheimer’s Disease (AD) requires a patient-centric, highly coordinated effort among a large multidisciplinary team of clinicians. As such, this proposed initiative establishes meaningful, small group interactions among key...
Treatment of Early-Stage Non-Small Cell Lung Cancer
Immunotherapy, which has demonstrated benefits in advanced and metastatic settings, is moving into early non-small cell lung cancer treatment, expanding options for patients with resected or resectable early-stage non-small cell lung cancer. This rapid evolution of the early NSCLC treatment...
The Good Fight – Overcoming Challenges to Combat Obesity and Overweight 2024
In the United States, obesity and overweight are an epidemic and a major health concern worldwide. Excess adipose tissue can lead to diabetes, hypertension, cardiovascular disease, certain cancers, poor mental health, and musculoskeletal disorders, resulting in decreased quality of life and...
Optimizing Treatment for Patients with CLL
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in Western countries, with an age-adjusted incidence of 4.6 per 100,000 individuals per year. As small lymphocytic lymphoma (SLL) refers to the same malignant process with primary nodal involvement rather than blood, these are...
New Opportunities in the Care of Patients with Duchenne Muscular Dystrophy
The goal of this initiative is to improve the care of patients with Duchenne muscular dystrophy (DMD). DMD is the most common childhood form of muscular dystrophy and characteristic manifestations are progressive muscle weakness, cardiorespiratory impairment, and premature death. Gene therapy...
Treating Immune-Mediated, Inflammatory Diseases with Janus Kinase (JAK) Inhibitors
Immune-mediated inflammatory diseases, such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, can prove challenging to address in real-world settings. Although biologics directed against TNF-α can rapidly and sustainably induce clinical remission of these conditions, they...
Achieving Access to High-Quality Care Across the Spectrum of Age and Patient Type to Improve Overall Outcomes for Atopic Dermatitis
Managed care professionals are not on the forefront of dermatologic care for those pediatric and adult patients living with atopic dermatitis. In this program, learners will explore the challenges patients living with atopic dermatitis face and they will identify opportunities to collaborate and...
Agents of Change: Improving the Collaboration Among CAR T Center Experts and Community-Based Clinicians for Improved Care of DLBCL Patients
This dynamic curriculum, detailed by a specialty center clinician, explores each of the CD 19-directed CAR T-cell therapies available for the treatment of DLBCL; solutions to referral and logistic challenges; in-depth early and late toxicity management in CAR T-cell treatment; and the delivery of...
Striking a Balance: Understanding Pain Management and Opioids
Striking a Balance: Understanding Pain Management and Opioids, thoughtfully balances the risks and benefits of safe opioid prescribing. It covers: effective patient assessment, creating patient-centered pain treatment plans, non-pharmaceutical pain treatment options, managing patients on opioid...
Unlocking The Potential Of Breakthroughs In NSCLC Therapeutic Approaches
The proposed activities will inform clinicians of recent evidence from clinical trials on the efficacy and safety of TROP2-directed antibody-drug conjugates (ADCs) in patients with progressive NSCLC, allowing them to quickly integrate new treatments into their practice when they become available....
Relief In Sight – Understanding The Burden Of Spondyloarthritis
This interactive online activity uses self-study and group discussion modules on a collaborative platform to examine various facets about spondyloarthritis (SpA) conditions. Learn more about differentiating SpA for a timely diagnosis and targeted treatments including IL-17 antagonists, as well as...
Managing Prurigo Nodularis – Latest Advances And Strategies
Considering the significant impact Prurigo Nodularis (PN) has on patients’ quality of life, it is critical for patients to receive a timely diagnosis and oftentimes can be difficult to treat. Furthermore, understanding the underlying pathogenesis is important to determine the optimal treatment...
Comprehensive Approaches To Addressing Atopic Dermatitis In Very Young Patients
This curriculum on Comprehensive Approaches to Addressing Atopic Dermatitis in Very Young Patients is designed to equip healthcare professionals with a thorough understanding of effective strategies for managing and treating atopic dermatitis in infants and toddlers. This program integrates the...
A Rash Of Developments In Chronic Spontaneous Urticaria Treatment And Management
Chronic spontaneous urticaria (CSU) is a prevalent, potentially debilitating disease that can prove challenging to manage successfully. Although antihistamines, anti-IgE monoclonal antibodies, and off-label suppressants can alleviate recurrent hives and angioedema, many patients with CSU are...
Unlocking the Complex Management of Short Bowel Syndrome
Surgical removal of parts of the small intestine can lead to short bowel syndrome (SBS), causing disruptions in electrolyte balance, fluid absorption, and nutrition. Explore the management of SBS symptoms and strategies for enhancing intestinal adaptation to help patients reach the goal of enteral...
Advancements in Treating Early-Stage Biochemical Recurrence in Hormone-Sensitive Prostate Cancer
This collaborative social learning platform establishes a network of providers who can support each other locally, as well as those from different communities, with the goal of learning and sharing best practices that will improve outcomes for patients with non-metastatic hormone-sensitive...
New Perspectives in the Front-line Treatment of Metastatic Bladder Cancer
Advanced and metastatic urothelial carcinoma (a/mUC) of the bladder comprises a small subset of all urothelial tumors but accounts for the majority of the rapid mortality associated with this disease. Over the last decade, accelerating basic science research has enabled a deeper understanding of...
Assessing and Managing IBS-C
Learn the best practice guidelines for diagnosing and treating IBS-C and how to effectively communicate with patients with IBS to improve clinical outcomes and increase patient and provider satisfaction.
The Multiple Myeloma Patient Journey
Multiple myeloma is the second-most-common hematologic malignancy in the United States with approximately 34,470 new cases diagnosed in the United States in 2022. Although multiple myeloma is an incurable disease, numerous active agents are available that, when used in combination, often lead to...
Empowering a Multidisciplinary Community to Improve Timely Diagnosis and Treatment of Thyroid Eye Disease
This educational program focuses on the recognition, diagnosis, and management of patients with thyroid eye disease, the majority of whom remain undiagnosed and unaware of treatment options. The program combines flexible, self-directed learning, live group discussions, and collaborative group case...
How MS Care Has Evolved Since the COVID-19 Pandemic
As a result of the COVID-19 pandemic, we have learned valuable lessons pertinent to MS care. This includes knowledge about COVID-19 severity and infection risk (especially as it relates to DMT selection), a much greater understanding of how DMTs affect SARS-CoV-2 vaccine responses, ways to...
Turning Complexity into Clarity in Chronic Immune-Mediated Neuropathies
Often seen in Guillain–Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy (MMN), arise as a consequence of immune system involvement and can have myriad health consequences. Both CIDP and MMN are characterized by complex presentations and...
Unlocking the Gaps to Improve SMA Outcomes
Spinal muscular atrophy (SMA) can be a debilitating condition causing immobility, respiratory difficulties, and reduced lifespan. But with the advent of new disease-modifying therapies, the prognosis for patients with SMA has been completely altered. These treatments may help patients live longer,...
Unveiling Anemia in Myelodysplastic Syndrome
Welcome to our interactive and engaging educational initiative on managing anemia in myelodysplastic syndromes (MDS). Anemia is a common issue in MDS, causing symptoms like fatigue, pallor, shortness of breath, and light-headedness. It can have a significant impact on patients' quality of life and...
Addressing the Challenges in Alzheimer’s Disease Diagnosis and Management
Alzheimer’s disease (AD) is the leading cause of cognitive impairment and dementia in older individuals (≥ 65 years) throughout the world. In the United States (U.S.), more than 6 million individuals carry this diagnosis, with many yet to be diagnosed. AD follows a prolonged, progressive disease...
Activating Clinicians to Deliver Effective Obesity Care
Approximately 70% of all adults in the United States are overweight or have obesity. Unfortunately, obesity remains underdiagnosed and inadequately addressed in routine practice. While enormous strides have been made in recent years relative to the safety and efficacy of anti-obesity medications...
Advanced Endometrial Cancer in the Immunotherapy Age
Endometrial cancer is among the few cancers increasing in incidence and mortality in the United State and remains the most common gynecologic cancer diagnosed. To improve clinical outcomes, clinicians treating patients with endometrial cancer need to understand the molecular classification of the...
Turning Complexity into Clarity in HAE Prophylaxis
Hereditary angioedema (HAE) is a rare but potentially life-threatening disease affecting approximately 1 in 67,000 individuals, with no identified differences in prevalence due to sex or ethnicity. The disease commonly presents with recurrent attacks of swelling in any part of the body. Given the...
Expert Guidance on Cataract and Refractive Surgery: Clinical Reasoning Skills for the Young Surgeon
Join this digital educational program that connects you with 10 like-minded early career ophthalmic surgeons and an expert Group Leader to review and discuss the latest developments in cataract and refractive surgery. This personalized mentorship model prioritizes learner-to-learner and...
Meeting the Challenge of Chronic Pain Management in an Ever-Evolving Opioid Epidemic: 2024
Assessment and treatment of pain are challenges for healthcare providers and health systems. Treatment with opioid medications can decrease pain functionality but also may result in opioid tolerance, dependence, misuse, and overdose. It is important that opioids be prescribed judiciously to...
Eye-Connect: Optimal Management of Diabetic Retinopathy: Leveraging the Treatment Evidence
New data regarding the use of anti-vascular endothelial growth factor (VEGF) prophylaxis in patients with moderate to severe nonproliferative diabetic retinopathy without diabetic macular edema underscore the need for an evidence-based shift to proactive diabetic retinopathy (DR) treatment (rather...
Targeting Mealtime Glucose Excursions and Glycemic Control in T2DM – How and When Should We Use Newer Insulins?
This curriculum focuses on improving outcomes for patients with T2DM who are likely to benefit from the addition of a newer insulin, such as an MTI, to their therapeutic regimen and improving the delivery of telehealth services to underserved patients with T2DM via a multidisciplinary team approach.
Managing BRAF V600-mutant Colorectal Cancer
Colorectal cancer (CRC) continues to be the second most lethal cancer in the United States (US) with approximately 149,500 new cases and 52,980 deaths per year. Patients diagnosed at an advanced/metastatic stage have a five-year survival rate of roughly 14%. For these patients, initial treatment...
Oncology Innovations: Metastatic Non-Small Cell Lung Cancer
This interactive program updates learners on the latest guideline recommendations for biomarker identification and application in NSCLC. The program will enable learners to select appropriate personalized treatment pathways based on the tumor profile, while incorporating the latest scientific...
Reaching and Teaching Community-Based Clinicians to Improve Outcomes in CAR T-cell Therapy for DLBCL
3.5-credit-hour educational curriculum that brings together 10 groups of 10 professionally connected clinicians led by an expert (called a Group Leader) to comprehensively review key information and best practices to help clinicians formulate their own practice action plans in the care of patients...
Eye-Connect: Patient-Focused Management of Diabetic Care and Vision Screening and Referral for Diabetic Retinopathy
Diabetic retinopathy and diabetic macular edema affect a majority of patients with diabetes, but there are ways to mitigate its progression. You'll learn practical strategies to help patients save their sight and you'll discuss the integration of novel screening and diagnostic technology into...
Multiple Myeloma Health Professional Needs Assessment Research Study
This research study explores the practices, beliefs, and priorities of health professionals treating Multiple Myeloma in order to identify key educational needs and interests. Through small, peer-led online groups, participating clinicians engage in self-assessments, a case-based group activity,...
Addressing the Complexities of MS Care during COVID
Since the beginning of the COVID-19 pandemic, there have been reservations regarding the risks of using immunosuppressive or immunomodulating agents to treat patients with multiple sclerosis (MS) in case these treatments increase infectious disease risk or reduce vaccine efficacy. Many MS patients...
New Directions in Atopic Dermatitis Management
Clinically heterogeneous presentation, with only intermittent symptoms and long latent periods for some patients, along with manifestations that overlap with other skin conditions make the diagnosis of atopic dermatitis difficult for clinicians, resulting in delays in diagnosis and treatment....
A Collaborative Approach to IBD Management: Meaningful Engagement for Whole-Patient Care
A CME/CE-certified curriculum using a small-group platform with meaningful peer-to-peer interactions. The course focuses on implementing a collaborative approach in primary care and gastroenterology settings to improve patient care.
Integrating Continuous Glucose Monitoring Into Diabetes Care: Meaningful Engagement for Improved Patient Outcomes
This CME/CE-certified curriculum has been developed to establish impactful small group interactions between members of the diabetes care team that will, through a variety of collaborative educational experiences, help them to fully integrate CGM into daily practice.
Improving the Care of Patients with Advanced Renal Cell Carcinoma
Renal cell carcinoma (RCC) remains the most common variety of renal cancer, representing 90% of the diagnoses. Within the United States (US), it is a relatively common malignant caner, ranking as sixth and tenth most common for men and women respectively. Yet, the incidence has been slowly but...
COPD Health Professional Needs Assessment Research Study
This research study will explore current and future practices, beliefs, and priorities of health professionals treating COPD in order to identify their educational needs and interests. The study is conducted in the setting of small, peer-led digital groups of clinicians who will be engaging in...
Mastering the Evolving Treatment Landscape in HER2-Positive Breast Cancer: Current Guidance and Future Perspectives
This CME/CE/CPE-certified activity has been developed to bring together different members of the breast cancer care team in small-group virtual workshops that allow interactions through various collaborative educational experiences. The goal of this activity is to improve the knowledge,...
Acute Myeloid Leukemia: Evidence-Based Guidance on Current Paradigms and New Therapeutic Approaches
This program is designed to offer an expert-led interactive approach to providing optimal care for patients with acute myeloid leukemia (AML). Topics discussed will include creating and implementing multidisciplinary, evidence-based, and patient-specific plans for the management of treatment-naive...
Turning Complexity into Clarity in Advanced Cervical Cancer
The current treatment of advanced, recurrent, and metastatic cervical cancer is difficult, especially as treatment progresses to the second line. Considerations for treatment are nuanced and numerous. Factors include prior treatments, treatment timing, and patient preference. The advent of...
Geographic Atrophy: What to Look For and When to Refer
This COPE-certified small group educational experience is designed for optometrists involved in the management of patients with geographic atrophy (GA). Key goals of the curriculum are: ~ Discuss the prevalence of age-related macular degeneration ~ Articulate the burden of illness linked to...
Meeting the Challenge of Pain Management in an Ever-Evolving Opioid Epidemic
Assessment and treatment of pain are challenges for healthcare providers and health systems. Treatment with opioid medications can decrease pain functionality but also may result in opioid tolerance, dependence, misuse, and overdose. It is important that opioids be prescribed judiciously to...
Turning Complexity into Clarity in AML
Acute myeloid leukemia (AML) continues to be the most common acute leukemia in adults, with an incidence of 5.5 cases per 100,000 persons annually. As such, more education is needed on key topics including use of induction therapy in the non-elderly population, treating suboptimal response to...
Chronic Rhinosinusitis With Nasal Polyps: Considering Systemic Management Approaches to Optimize Outcomes
This interactive program discusses foundational knowledge on chronic rhinosinusitis with nasal polyps (CRSwNP) with respect to patient quality of life, disease progress, and underlying immunologic processes. In addition, it reviews the efficacy and safety of standard and novel treatment options....
Treating Hepatitis C in the Primary Care Setting
This online, interactive curriculum will provide continuing education (CME/CE) for primary care providers (PCPs) to support their competence and confidence in treating patients with chronic hepatitis C virus (HCV) infection. Small-group workshops will utilize novel collaborative-education...
A Comprehensive Approach to Optimizing Glycemic Control
This CME/CE-certified activity has been developed with the aim of bringing together different members of the diabetes care team in small group virtual workshops that allow interactions through a variety of collaborative educational experiences. The goal of this education is to improve the use of...
Contemporary Approaches to Relapsed/Refractory Multiple Myeloma
The purpose of this curriculum is to improve the performance of learners to apply practice-changing clinical data and expert recommendations in order to optimize clinical outcomes with BCMA-targeted therapies for their patients with relapsed/refractory multiple myeloma. This will be achieved with...
Improving Beta-thalassemia Outcomes
With the increase in the lifespan of patients with beta thalassemia and demographic shifts in the U.S., hematologists are treating more patients with this condition. As such, more education is needed on key topics including disease fundamentals, transitioning patients to adult care, new and...
Modernizing Care of Patients with BCC: Changes in Management Approaches
This small group educational experience is designed for MDs, PA, RNs & NPs involved in the management of patients with basal cell carcinoma (BCC). Key goals of the curriculum are: • Identify patients for whom hedgehog inhibitor therapy may no longer be viable due to lack of response or adverse...
Improving Management of Advanced Non-Melanoma Skin Cancer
Improving Management of Advanced Non-Melanoma Skin Cancer is a comprehensive, evidence-based curriculum about the challenges in identifying patients at high risk for mBCC and la/mCSCC, screening methods and staging of these patients, and the new and emerging therapies for patients with NMSC. By...
Best Practices in Early-Stage NSCLC
This CE initiative will offer a roughly 4-week digital curriculum to interprofessional learners. The goal of the initiative is to establish meaningful, small group interactions between clinicians involved in the care of patients with early stage NSCLC that will, through a variety of collaborative...
Lighting the Fire: Improving Racial Parity in Oncology
The goal of this dynamic curriculum is to reduce individual and systemic barriers to actively address disparities in the delivery of cancer care impacting outcomes for black men and women facing cancer.
Optimal Identification and Management of Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension (PAH) is a progressive disease and is associated with poor clinical outcomes. Data from the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) has shown that the diagnosis of PAH is often missed or delayed with the average length of time from...
A Multidisciplinary Team Approach to Patient-Centric Management of Fabry Disease
Patients with Fabry disease (FD) have a significantly shorter life expectancy compared to the general population, often due to cardiac or renal complications of this rare disease. There are only 2 approved therapies for FD—enzyme replacement therapy and chaperone therapy. Management of FD and its...
Making Sense of the Evolving Standards of Care for Advanced HER2+ Breast Cancer
The overall goal of this CE initiative is to establish meaningful, small group interactions between clinicians involved in the care of patients with breast cancer that will, through a variety of collaborative educational experiences, help them optimally manage HER2-positive breast cancer patients...
Osteoarthritis and Pain: Intensive Training in Pain Management
Osteoarthritis and Pain: Intensive Training in Pain Management is a comprehensive evidence-based presentation about the burden of osteoarthritis (OA) and OA pain, the challenges of current pharmacologic and nonpharmacologic strategies, and evidence about the role of nerve growth factor in...
Networks in Neurology: A Virtual Collaboration of Specialists and Practicing Neurologists on the Effective Integration of New Agents and Strategies for Multiple Sclerosis
MS is the leading cause of non-traumatic disability in adults over the age of 50 and has become a focus of evolving research. In just the past two decades, a greater understanding of the pathogenesis of MS has led to a litany of new FDA approved therapies. In fact, there are now 18 DMTs...
Accelerating New Standards of Oncology Care Amidst the Global Pandemic: Operational, Clinical, and Interpersonal Considerations
There is an urgent and ongoing need to provide cancer care professionals with guidance, training, and support during the COVID-19 pandemic as they respond to unprecedented challenges in maintaining high-quality patient care. Members of the care team are challenged by the rapidly evolving data and...